RealFeedApp US regulators approve NeuroXT NEXT-Cue for sale as AI medical device
NeuroXT's NEXT-Cue software analyzes brain MRI and cognitive scores to detect Alzheimer's progression in patients with mild cognitive impairment.
- Field
- medicine and diagnostics
- What they did
- NeuroXT has received FDA clearance for its software NEXT-Cue, which combines brain MRI scans with cognitive test scores.
- Why it matters
- This will help clinicians better assess the risk of developing Alzheimer's disease in patients with mild cognitive impairment.
#alzheimer's#mri#fda#ai#diagnosis
